Related Experiment Video

Updated: Jun 5, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND

Prashanthi Vemuri1, Gyorgy Simon, Kejal Kantarci

  • 1Department of Radiology, Mayo Clinic and Foundation, Rochester, MN 55905, USA. vemuri.prashanthi@mayo.edu

Neuroimage
|January 4, 2011
PubMed

Insights

This study identifies unique brain atrophy patterns for Alzheimer's disease (AD), Lewy body disease (LBD), and frontotemporal lobar degeneration (FTLD) using MRI. The developed Differential-STAND system accurately differentiates these dementia types based on these structural abnormalities.

Area of Science:

  • Neuroimaging
  • Neuropathology
  • Medical Diagnostics

Background:

  • Dementia diagnosis relies on clinical assessment, often lacking definitive pathological confirmation during life.
  • Alzheimer's disease (AD), Lewy body disease (LBD), and frontotemporal lobar degeneration (FTLD) are common neurodegenerative pathologies underlying dementia, each with distinct clinical and pathological features.
  • Accurate differential diagnosis is crucial for appropriate patient management and therapeutic strategies.

Purpose of the Study:

  • To identify distinct patterns of brain atrophy associated with pathologically confirmed AD, LBD, and FTLD-TDP using antemortem structural MRI.
  • To develop and validate an MRI-based differential diagnosis system (Differential-STAND) for neurodegenerative dementias.

Main Methods:

  • Structural MRI scans from 48 AD, 20 LBD, and 47 FTLD-TDP patients with pathological confirmation were analyzed.
  • Gray matter density in 91 regions-of-interest was measured and compared to 120 cognitively normal controls.
  • A mixture model based on bisecting k-means clustering was used for classification, with leave-one-out cross-validation.

Main Results:

  • Distinct atrophy patterns were observed: AD-temporoparietal and medial temporal lobes; FTLD-TDP-frontal and temporal lobes; LBD-amygdalae, dorsal midbrain, and inferior temporal lobes.
  • Differential-STAND achieved high classification performance: AD (90.7% sensitivity, 84% specificity), LBD (78.6% sensitivity, 98.8% specificity), and FTLD-TDP (84.4% sensitivity, 93.8% specificity).
  • The system demonstrated reasonable performance compared to autopsy and clinical diagnoses.

Conclusions:

  • Structural MRI can reveal specific topographic patterns of atrophy corresponding to distinct dementia pathologies.
  • The Differential-STAND system provides a reliable, MRI-based method for differential diagnosis of AD, LBD, and FTLD-TDP.
  • This approach links in vivo neuroimaging findings directly to pathological diagnoses, aiding in predicting underlying dementia pathology.

More Related Videos

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...